Veritas In Silico (TSE:130A) EBITDA Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Veritas In Silico's EBITDA for the three months ended in Dec. 2024 was 円0.0 Mil. Veritas In Silico's Revenue for the three months ended in Dec. 2024 was 円0.0 Mil. Therefore, Veritas In Silico's EBITDA margin for the quarter that ended in Dec. 2024 was 0.00%.

Veritas In Silico EBITDA Margin % Historical Data

The historical data trend for Veritas In Silico's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico EBITDA Margin % Chart

Veritas In Silico Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

EBITDA Margin %

-366.55

-60.45

17.92

-101.30

Veritas In Silico Quarterly Data
	Dec21	Dec22	Sep23	Dec23	Mar24	Jun24	Dec24
EBITDA Margin %	Get a 7-Day Free Trial			-	-2.51	-202.15	-2.04	-

Competitive Comparison of Veritas In Silico's EBITDA Margin %

For the Biotechnology subindustry, Veritas In Silico's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Veritas In Silico's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veritas In Silico's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Veritas In Silico's EBITDA Margin % falls into.

Save Embed

;

Save Embed

;

Veritas In Silico EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Veritas In Silico's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-197.178	/	194.643
	=	-101.30 %

Veritas In Silico's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	0	/	0
	=	%

Veritas In Silico (TSE:130A) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Veritas In Silico EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Veritas In Silico Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031

Website

https://www.veritasinsilico.com

Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines